Novozymes A/S (NVZMY)

OTC Markets OTCPK Currently up 0.57 (+0.88%) in today's trading session

1 member of Congress has disclosed 5 trades in Novozymes A/S (NVZMY) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 1 June 2026. Aggregate disclosed activity totals roughly $32K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Novozymes A/S is currently trading at $65.06, positioned at 71% of its 52-week range ($49.90 – $71.37).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$65.06
24h Change
+0.57 (+0.88%)
52 Week Range
$49.90$71.37
View on NASDAQ

Novozymes A/S Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for NVZMY

Select to highlight on chart
2 transactions
Compliance: 40%
Josh Gottheimer1 Jun 20267 Jul 2026SaleStock$1,001 - $15,000N/A
Josh Gottheimer11 Oct 201816 Nov 2018PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$30.33B

Volume

2.88K

Beta

0.62

P/E Ratio

67.45

Fundamentals

EPS

$0.96

Div. Yield

0.69%

Open

$64.69

Day Range

$64.64 — $65.17

Company Information

Sector
Basic Materials
Industry
Chemicals - Specialty
Exchange
OTC · USD
Country
DK
CEO
Ester Baiget
IPO Date
2010-01-20

Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America...

Earnings

Next Report

Q2 2026

20 Aug

EPS Est.

$0.77

Rev. Est.

$1.3B

Days Until

40

Recent Quarters

Q1 20265 May
EPS$0.51
Miss 37.5%
Q4 202525 Feb
EPS$0.35
Miss 55.8%
Q2 202521 Aug
EPS$0.05
Miss 93.2%
Q1 20258 May
EPS$0.06
Miss 86.5%
Q4 202427 Feb
EPS$0.07
Miss 93.3%
Q3 202428 Nov
EPS$0.48
Miss 16.7%
Q2 202428 Aug
EPS$0.12
Miss 82.7%
Q1 202429 May
EPS$0.12
Miss 78.0%
Q4 20231 Feb
EPS$0.36
Miss 23.4%
Q3 202326 Oct
EPS$0.49
Beat 16.7%
Q2 20239 Aug
EPS$0.32
Miss 23.8%
Q1 202326 Apr
EPS$2.82
Miss 5.7%
Q4 202226 Jan
EPS$0.44
Beat 7.8%
Q3 20223 Nov
EPS$0.56
Beat 3.7%
Q2 202211 Aug
EPS$0.41
Beat 5.1%
Q1 202226 Apr
EPS$0.45
Beat 4.0%
Q4 20211 Feb
EPS$0.36
Miss 84.9%
Q3 202126 Oct
EPS$0.48
Miss 81.3%
Q2 202112 Aug
EPS$0.46
Beat 12.2%
Q1 202127 Apr
EPS$0.51
Beat 13.3%
Q4 20202 Feb
EPS$0.37
Miss 11.9%
Q3 202021 Oct
EPS$0.40
Q2 202011 Aug
EPS$0.34
Miss 2.9%
Q1 202029 Apr
EPS$0.42
Miss 4.5%
Q4 201923 Jan
EPS$0.48
Q3 201923 Oct
EPS$0.33
Miss 23.3%
Q2 20198 Aug
EPS$0.47
Miss 11.3%
Q1 201924 Apr
EPS$0.37
Q4 201824 Jan
EPS$0.44
Beat 4.8%
Q3 201824 Oct
EPS$0.43
Q2 201810 Aug
EPS$0.43
Beat 0.0%
Q1 201825 Apr
EPS$0.45
Beat 2.3%
Q4 20177 Feb
EPS$0.43
Miss 6.5%
Q3 201725 Oct
EPS$0.44
Q2 201711 Aug
EPS$0.36
Miss 7.7%
Q1 201726 Apr
EPS$0.37
Beat 2.8%
Q4 201618 Jan
EPS$0.39
Q3 201627 Oct
EPS$0.37
Q2 201610 Aug
EPS$0.37
Q1 201620 Apr
EPS$0.36
Q4 201519 Jan
EPS$0.33
Beat 6.5%
Q3 201522 Oct
EPS$0.36
Beat 0.0%
Q2 20156 Aug
EPS$0.33
Miss 5.7%
Q1 201523 Apr
EPS$0.33
Beat 0.0%
Q4 201420 Jan
EPS$0.30
Beat 30.4%
Q3 201423 Oct
EPS$0.34
Miss 5.6%
Q2 201414 Aug
EPS$0.34
Miss 8.1%
Q1 201424 Apr
EPS$0.40
Beat 21.2%
Q4 201321 Jan
EPS$0.31
Q3 201325 Oct
EPS$0.33
Q2 20139 Aug
EPS$0.31
Miss 8.8%
Q1 201325 Apr
EPS$0.28
Miss 6.7%
Q4 201221 Jan
EPS$0.27
Q3 201225 Oct
EPS$0.28
Miss 6.7%
Q2 201216 Aug
EPS$0.27
Beat 0.0%
Q1 201225 Apr
EPS$0.28
Beat 12.0%
Q4 201119 Jan
EPS$0.20
Miss 9.1%
Q3 201128 Oct
EPS$0.29
Beat 7.4%
Q3 201128 Oct
EPS$0.29
Beat 7.4%
Q4 201031 Mar
EPS$0.29
Q4 201021 Jan
EPS
Q3 201028 Oct
EPS$0.24
Beat 14.3%
Q3 201028 Oct
EPS$0.24
Beat 14.3%
Q4 200931 Mar
EPS$0.23
Q3 200931 Dec
EPS$0.19
Q2 200930 Sept
EPS$0.20
Q1 200930 Jun
EPS$0.17
Q4 200831 Mar
EPS$0.17

2 politicians traded within 30 days

Dividends

Dividend History

25 Mar 2026
Amount $0.1005
2 Sept 2025
Amount $0.3504
7 Apr 2025
Amount $0.6136
9 Sept 2024
Amount $0.2980
1 May 2024
Amount $0.2890
20 Oct 2023
Amount $0.5938
3 Mar 2023
Amount $0.8770
17 Mar 2022
Amount $0.8452
12 Mar 2021
Amount $0.8492
27 Feb 2020
Amount $0.7800
28 Feb 2019
Amount $0.7590
14 Mar 2018
Amount $0.7410
22 Feb 2017
Amount $0.5730
24 Feb 2016
Amount $0.5099
3 Mar 2015
Amount $0.4494
27 Feb 2014
Amount $0.4600
1 Mar 2013
Amount $0.3940
1 Mar 2012
Amount $0.3380
3 Mar 2011
Amount $0.2924
4 Mar 2010
Amount $0.2104
5 Mar 2009
Amount $0.1779
10 Mar 2008
Amount $0.2058
9 Mar 2007
Amount $0.1594
2 Mar 2006
Amount $0.1274
17 Mar 2005
Amount $0.1220
18 Mar 2004
Amount $0.1036

Stock Splits

Split History

9 Dec 2011Stock Split
Ratio5:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MSFT

Microsoft Corporation

42
$385.10+0.74 (+0.19%)
Technology
Held by same politician
$23M in total holdings
1 politician
View Stock

VOO

Vanguard S&P 500 ETF

22
$693.86+3.17 (+0.46%)
Financial Services
Held by same politician
Significant holdings value
1 politician
View Stock

AAPL

Apple Inc.

20
$315.32-0.90 (-0.28%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about NVZMY

Which members of Congress have traded NVZMY?
1 member of Congress has disclosed 5 trade in Novozymes A/S (NVZMY) under the STOCK Act: Josh Gottheimer.
When was NVZMY most recently disclosed by Congress?
The most recent NVZMY disclosure was a sale by Josh Gottheimer on 1 June 2026.
What is the total disclosed congressional trading volume for NVZMY?
Members of Congress have disclosed approximately $32K in NVZMY purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in NVZMY?
This NVZMY page updates as soon as new STOCK Act disclosures are filed for Novozymes A/S. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.